Creative Medical Technology Holdings, Inc. (CELZ) Financials

CELZ Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 6.4 million 307649
Dec. 31, 2025 7.8 million 284880
Sept. 30, 2025 5.9 million 261353
June 30, 2025 7.1 million 277644

CELZ Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.3 million ?
Dec. 31, 2025 -1.9 million ?
Sept. 30, 2025 -1.2 million ?
June 30, 2025 -1.2 million ?

CELZ Net Income

No data available :(

CELZ Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.8 million - -
Dec. 31, 2025 7.2 million - -
Sept. 30, 2025 5.4 million - -
June 30, 2025 6.5 million - -

CELZ Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 3.7 million
Dec. 31, 2025 2.4 million
Sept. 30, 2025 2.6 million
June 30, 2025 2.6 million

CELZ Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 541658 888640 -
Dec. 31, 2025 4 550077 1.4 million -
Sept. 30, 2025 - 465154 776821 -
June 30, 2025 3 501260 731517 -

CELZ Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 28855
Dec. 31, 2025 3000 31943
Sept. 30, 2025 - 31059
June 30, 2025 - 30742

CELZ

Price: $0.81

52 week price:
0.79
6.25

Earnings Per Share: -2.52 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 183800

Market Capitalization: 3.1 million

Links: